Castleman disease lymphadenopathy in the Era of HIV. Pitfalls in diagnosis and their avoidance

G. V. Chaithra, Debarshi Saha, Beshwant Chowdary, M. Nirupama

Research output: Contribution to journalArticle

Abstract

Castleman disease and HIV-lymphadenitis share similar morphologies, but they can be identified separately. We retrospectively studied 16 cases diagnosed as Castleman disease over a seven-year-period. Four HIV-infected patients (two men and women) with lymphadenitis and 10 Castleman disease cases were obtained. All patients with Castleman disease had unicentric disease except one with multicentric variety. All had characteristic follicular morphologies and four of them also had interfollicular changes. The HIV-lymphadenites showed similar follicular morphologies except for conspicuous concentric ringing in the broadened mantle zone. Additionally, in the interfollicular region, plasmacytoid cells were found. None of the Castleman disease recurred after surgery, except the multicentric case who continue to suffer and is currently being treated with chemotherapy. The remaining two cases were one each of follicular lymphoma and follicular hyperplasia. Castleman disease is a well-defined lymphadenopathy characterized by small follicles, diminished sinuses, broadened mantle zones with concentric ringing of lymphocytes around hyalinized germinal centers composed of follilcular dendritic cells. HIV-lymphadenitis progresses from follicular hyperplasia to a hyalinized, fibrotic node with sclerotic germinal centers, plasma cells and marked angiogenesis. In spite of numerous similarities, pathologists should not confuse one with the other because treatment implications are grave. A thorough clinical history aids in diagnosis.

Original languageEnglish
Pages (from-to)1720-1726
Number of pages7
JournalResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Volume7
Issue number6
Publication statusPublished - 01-11-2016

Fingerprint

Giant Lymph Node Hyperplasia
HIV
Lymphadenitis
Germinal Center
Hyperplasia
Follicular Lymphoma
Chemotherapy
Plasma Cells
Lymphocytes
Dendritic Cells
Lymphadenopathy
Surgery
Drug Therapy
Plasmas

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Chaithra, G. V. ; Saha, Debarshi ; Chowdary, Beshwant ; Nirupama, M. / Castleman disease lymphadenopathy in the Era of HIV. Pitfalls in diagnosis and their avoidance. In: Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2016 ; Vol. 7, No. 6. pp. 1720-1726.
@article{e1ed49fe26fb4feb9cc3bf3bd5a5cbaa,
title = "Castleman disease lymphadenopathy in the Era of HIV. Pitfalls in diagnosis and their avoidance",
abstract = "Castleman disease and HIV-lymphadenitis share similar morphologies, but they can be identified separately. We retrospectively studied 16 cases diagnosed as Castleman disease over a seven-year-period. Four HIV-infected patients (two men and women) with lymphadenitis and 10 Castleman disease cases were obtained. All patients with Castleman disease had unicentric disease except one with multicentric variety. All had characteristic follicular morphologies and four of them also had interfollicular changes. The HIV-lymphadenites showed similar follicular morphologies except for conspicuous concentric ringing in the broadened mantle zone. Additionally, in the interfollicular region, plasmacytoid cells were found. None of the Castleman disease recurred after surgery, except the multicentric case who continue to suffer and is currently being treated with chemotherapy. The remaining two cases were one each of follicular lymphoma and follicular hyperplasia. Castleman disease is a well-defined lymphadenopathy characterized by small follicles, diminished sinuses, broadened mantle zones with concentric ringing of lymphocytes around hyalinized germinal centers composed of follilcular dendritic cells. HIV-lymphadenitis progresses from follicular hyperplasia to a hyalinized, fibrotic node with sclerotic germinal centers, plasma cells and marked angiogenesis. In spite of numerous similarities, pathologists should not confuse one with the other because treatment implications are grave. A thorough clinical history aids in diagnosis.",
author = "Chaithra, {G. V.} and Debarshi Saha and Beshwant Chowdary and M. Nirupama",
year = "2016",
month = "11",
day = "1",
language = "English",
volume = "7",
pages = "1720--1726",
journal = "Research Journal of Pharmaceutical, Biological and Chemical Sciences",
issn = "0975-8585",
publisher = "RJPBCS",
number = "6",

}

Castleman disease lymphadenopathy in the Era of HIV. Pitfalls in diagnosis and their avoidance. / Chaithra, G. V.; Saha, Debarshi; Chowdary, Beshwant; Nirupama, M.

In: Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 7, No. 6, 01.11.2016, p. 1720-1726.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Castleman disease lymphadenopathy in the Era of HIV. Pitfalls in diagnosis and their avoidance

AU - Chaithra, G. V.

AU - Saha, Debarshi

AU - Chowdary, Beshwant

AU - Nirupama, M.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Castleman disease and HIV-lymphadenitis share similar morphologies, but they can be identified separately. We retrospectively studied 16 cases diagnosed as Castleman disease over a seven-year-period. Four HIV-infected patients (two men and women) with lymphadenitis and 10 Castleman disease cases were obtained. All patients with Castleman disease had unicentric disease except one with multicentric variety. All had characteristic follicular morphologies and four of them also had interfollicular changes. The HIV-lymphadenites showed similar follicular morphologies except for conspicuous concentric ringing in the broadened mantle zone. Additionally, in the interfollicular region, plasmacytoid cells were found. None of the Castleman disease recurred after surgery, except the multicentric case who continue to suffer and is currently being treated with chemotherapy. The remaining two cases were one each of follicular lymphoma and follicular hyperplasia. Castleman disease is a well-defined lymphadenopathy characterized by small follicles, diminished sinuses, broadened mantle zones with concentric ringing of lymphocytes around hyalinized germinal centers composed of follilcular dendritic cells. HIV-lymphadenitis progresses from follicular hyperplasia to a hyalinized, fibrotic node with sclerotic germinal centers, plasma cells and marked angiogenesis. In spite of numerous similarities, pathologists should not confuse one with the other because treatment implications are grave. A thorough clinical history aids in diagnosis.

AB - Castleman disease and HIV-lymphadenitis share similar morphologies, but they can be identified separately. We retrospectively studied 16 cases diagnosed as Castleman disease over a seven-year-period. Four HIV-infected patients (two men and women) with lymphadenitis and 10 Castleman disease cases were obtained. All patients with Castleman disease had unicentric disease except one with multicentric variety. All had characteristic follicular morphologies and four of them also had interfollicular changes. The HIV-lymphadenites showed similar follicular morphologies except for conspicuous concentric ringing in the broadened mantle zone. Additionally, in the interfollicular region, plasmacytoid cells were found. None of the Castleman disease recurred after surgery, except the multicentric case who continue to suffer and is currently being treated with chemotherapy. The remaining two cases were one each of follicular lymphoma and follicular hyperplasia. Castleman disease is a well-defined lymphadenopathy characterized by small follicles, diminished sinuses, broadened mantle zones with concentric ringing of lymphocytes around hyalinized germinal centers composed of follilcular dendritic cells. HIV-lymphadenitis progresses from follicular hyperplasia to a hyalinized, fibrotic node with sclerotic germinal centers, plasma cells and marked angiogenesis. In spite of numerous similarities, pathologists should not confuse one with the other because treatment implications are grave. A thorough clinical history aids in diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=84996644802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996644802&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 1720

EP - 1726

JO - Research Journal of Pharmaceutical, Biological and Chemical Sciences

JF - Research Journal of Pharmaceutical, Biological and Chemical Sciences

SN - 0975-8585

IS - 6

ER -